Mutations in PLOD3, encoding lysyl hydroxylase 3, cause a complex connective tissue disorder including recessive dystrophic epidermolysis bullosa-like blistering phenotype with abnormal anchoring fibrils and type VII collagen deficiency.


Journal

Matrix biology : journal of the International Society for Matrix Biology
ISSN: 1569-1802
Titre abrégé: Matrix Biol
Pays: Netherlands
ID NLM: 9432592

Informations de publication

Date de publication:
08 2019
Historique:
received: 07 08 2018
revised: 16 11 2018
accepted: 16 11 2018
pubmed: 22 11 2018
medline: 12 5 2020
entrez: 22 11 2018
Statut: ppublish

Résumé

Epidermolysis bullosa (EB), the paradigm of heritable skin fragility disorders, is associated with mutations in as many as 20 distinct genes. One of the clinical variants, recessive dystrophic EB (RDEB), demonstrates sub-lamina densa blistering accompanied by alterations in anchoring fibrils due to mutations in COL7A1. In this study, we characterized a patient with widespread connective tissue abnormalities, including skin blistering similar to that in RDEB. Whole exome sequencing, combined with genome-wide homozygosity mapping, identified a homozygous missense mutation in PLOD3 encoding lysyl hydroxylase 3 (LH3). No mutations in COL7A1, the gene previously associated with RDEB, were detected. The level of LH3 was dramatically reduced in the skin and fibroblast cultures from the patient. The blistering in the skin occurred below the lamina densa and was associated with variable density and morphology of anchoring fibrils. The level of type VII collagen expression in the skin was markedly reduced. Analysis of hydroxylysine and its glycosylated derivatives (galactosyl-hydroxylysine and glucosyl-galactosyl-hydroxylysine) revealed marked reduction in glycosylated hydroxylysine. Collectively, these findings indicate that PLOD3 mutations can result in a dystrophic EB-like phenotype in the spectrum of connective tissue disorders and add it to the list of candidate genes associated with skin fragility.

Identifiants

pubmed: 30463024
pii: S0945-053X(18)30345-7
doi: 10.1016/j.matbio.2018.11.006
pii:
doi:

Substances chimiques

COL7A1 protein, human 0
Collagen Type VII 0
PLOD3 protein, human EC 1.14.11.-
Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase EC 1.14.11.4

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

91-106

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Auteurs

Hassan Vahidnezhad (H)

Molecular Medicine Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran; Department of Dermatology and Cutaneous Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.

Leila Youssefian (L)

Department of Dermatology and Cutaneous Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA; Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran; Genetics, Genomics and Cancer Biology PhD Program, Thomas Jefferson University, Philadelphia, PA, USA.

Amir Hossein Saeidian (AH)

Department of Dermatology and Cutaneous Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA; Genetics, Genomics and Cancer Biology PhD Program, Thomas Jefferson University, Philadelphia, PA, USA.

Andrew Touati (A)

Department of Dermatology and Cutaneous Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA; Drexel University College of Medicine, Philadelphia, PA, USA.

Sara Pajouhanfar (S)

Department of Dermatology and Cutaneous Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.

Taghi Baghdadi (T)

Department of Orthopedic Surgery, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Azam Ahmadi Shadmehri (AA)

Department of Molecular Genetics, Science and Research Branch, Islamic Azad University, Marvdasht, Fars, Iran.

Cecilia Giunta (C)

Connective Tissue Unit, Division of Metabolism, Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.

Marius Kraenzlin (M)

Medical Faculty of the University of Basel, Clinic for Endocrinology, Diabetes & Metabolism, University Hospital Basel, Basel, Switzerland.

Delfien Syx (D)

Center for Medical Genetics, Ghent University Hospital, 9000 Ghent, Belgium.

Fransiska Malfait (F)

Center for Medical Genetics, Ghent University Hospital, 9000 Ghent, Belgium.

Cristina Has (C)

Department of Dermatology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.

Su M Lwin (SM)

St John's Institute of Dermatology, King's College London, Guy's Campus, London.

Razieh Karamzadeh (R)

Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.

Lu Liu (L)

Viapath, St Thomas' Hospital, London, UK.

Alyson Guy (A)

Viapath, St Thomas' Hospital, London, UK.

Mohammad Hamid (M)

Molecular Medicine Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.

Ariana Kariminejad (A)

Kariminejad-Najmabadi Pathology & Genetics Center, Tehran, Iran.

Sirous Zeinali (S)

Molecular Medicine Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran; Kawsar Human Genetics Research Center, Tehran, Iran.

John A McGrath (JA)

St John's Institute of Dermatology, King's College London, Guy's Campus, London.

Jouni Uitto (J)

Department of Dermatology and Cutaneous Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA; Jefferson Institute of Molecular Medicine, Thomas Jefferson University, Philadelphia, PA, USA. Electronic address: Jouni.Uitto@jefferson.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH